Corrigendum to “PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer” [Cancer Lett. 598 (2024) 217112]
Cancer Letters · 2026-09 · 656 · 218673
DOI: 10.1016/j.canlet.2026.218673 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer Letters, 2026-09. Verfasst von Hongyan Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China; Medical School, Kunming University of S….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China; Medical School, Kunming University of Science and Technology, Kunming, 650500, China.
- Academy of Biomedical Engineering, Kunming Medical University, Kunming, 650500, China.
- State Key Laboratory of Molecular Oncology, MOE Key Laboratory of Protein Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, School of Pharmaceutical Sciences, Tsinghua University, Beiji…
- Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
- The Third Affiliated Hospital, Kunming Medical University, Kunming, 650118, China.
- Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China; School of Life Science, University of Science & Technology of China, Hefei, Anhui, 230027, China.
Zitieren
APA
Zhang, H., Zhang, L., He, Y., Jiang, D., Sun, J., Luo, Q., Liang, H., Wang, T., Li, F., Tang, Y., Yang, Z., Liu, W., Rao, Y., & Chen, C. (2026). Corrigendum to “PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer” [Cancer Lett. 598 (2024) 217112]. Cancer Letters, 656, 218673. https://doi.org/10.1016/j.canlet.2026.218673
Vancouver
Zhang H, Zhang L, He Y, Jiang D, Sun J, Luo Q, et al. Corrigendum to “PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer” [Cancer Lett. 598 (2024) 217112]. Cancer Letters. 2026;656:218673. doi:10.1016/j.canlet.2026.218673
BibTeX
@article{Zhang2026,
author = {Zhang, Hongyan and Zhang, Longlong and He, Yuna and Jiang, Dewei and Sun, Jian and Luo, Qianmei and Liang, Huichun and Wang, Tiantian and Li, Fubing and Tang, Yu and Yang, Zimo and Liu, Wenjing and Rao, Yu and Chen, Ceshi},
title = {Corrigendum to “PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer” [Cancer Lett. 598 (2024) 217112]},
journal = {Cancer Letters},
year = {2026},
volume = {656},
pages = {218673},
doi = {10.1016/j.canlet.2026.218673}
}
EUVIMED